ARCHIVES

IOM Committee Will Probe Duke Scandal Together With Other “Omics” Case Studies

This article is from The Cancer Letter archive.

Vol. 37 No. 01 | January 7, 2011

Download PDF Visit The Full Archive

Related Articles

Treatment Division Outlines Future Program Areas

January 24, 1975

Breast Cancer Rates Decline Most for Affluent White Women

February 26, 2010

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991

Remarks on HPV Vaccines, SPORE Funds Create Controversy for NCI’s John Niederhuber.

April 14, 2006

Von Eschenbach To Leave FDA Jan. 20, Says He Was “In Love” With The Agency.

December 19, 2008

Biotech Organization Endorses Measures On Orphan Drug Act

April 1, 1994